Dakota Wealth Management lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 39.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 16,875 shares of the healthcare conglomerate's stock after selling 11,033 shares during the period. Dakota Wealth Management's holdings in UnitedHealth Group were worth $8,838,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of the company. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the fourth quarter worth about $30,000. Kapitalo Investimentos Ltda purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at about $41,000. Finally, Copia Wealth Management bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $42,000. Institutional investors own 87.86% of the company's stock.
Analyst Upgrades and Downgrades
UNH has been the topic of several recent analyst reports. Raymond James Financial downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Royal Bank Of Canada dropped their price objective on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Barclays lowered their price target on UnitedHealth Group from $350.00 to $337.00 and set an "overweight" rating on the stock in a report on Wednesday, July 9th. JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a research report on Friday, June 20th. Finally, Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their target price for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $415.00.
Get Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Trading Down 2.9%
UNH stock traded down $8.77 during mid-day trading on Tuesday, reaching $291.81. 15,918,599 shares of the stock traded hands, compared to its average volume of 7,759,350. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The business has a 50-day moving average price of $310.37 and a two-hundred day moving average price of $437.45. The stock has a market capitalization of $264.71 billion, a PE ratio of 12.22, a PEG ratio of 1.44 and a beta of 0.45.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the business earned $6.91 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 3.03%. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.
Insiders Place Their Bets
In related news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John F. Rex bought 17,175 shares of the business's stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer directly owned 203,796 shares in the company, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by company insiders.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.